Age Related Macular Degeneration News and Research

RSS

Saving sight of millions by making eye injections safe and comfortable

Two eye surgeons have written a first-of-its-kind book to save the sight of millions of patients around the world by making eye injections safe and comfortable.

7 Aug 2018

Rt Hon Baroness Boothroyd launches Fight for Sight campaign to raise awareness of eye health

The Rt Hon Baroness Boothroyd is launching a Fight for Sight campaign to raise awareness of eye health and the need for vital eye research.

1 Aug 2018

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionize treatment for age-related macular degeneration.

20 Jul 2018

Improving quality of diet may play important role in protecting against AMD

An analysis of recent high-quality research reveals that diet may affect individuals' risks related to the development and progression of age-related macular degeneration. The findings are published in Clinical & Experimental Ophthalmology.

4 Jul 2018

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

The advent of electronic medical records with large image databases, along with advances in artificial intelligence with deep learning, is offering medical professionals new opportunities to dramatically improve image analysis and disease diagnostics.

29 Jun 2018

Fight for Sight funds research to develop new drop-based drug for patients with wet AMD

Eye research charity Fight for Sight has today announced funding for a research project that could help see an end to eye injections for patients with wet age-related macular degeneration (AMD).

21 Jun 2018

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and Personalized Medicine.

19 Jun 2018

Microglia play protective role in response to retinal detachment, shows study

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.

19 Jun 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

New lab-on-a-chip device shows promise in treating retinal diseases

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.

10 May 2018

New studies show potential for using genetic information to create personalized vision care

Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

30 Apr 2018

Healthy diet can be key to preventing age-related macular degeneration

There is no permanent cure for age-related macular degeneration, the leading cause of vision loss in adults ages 50 and older affecting about 10 million Americans.

10 Apr 2018

Aging immune cells increase risk for macular degeneration

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States.

5 Apr 2018

First-in-human clinical trial of retinal implant to treat dry AMD

Age-related macular degeneration (AMD) affects more than 1.75 million individuals in the United States. Because the population is aging, that number will increase to almost 3 million by 2020. Between 80 and 90 percent of cases in this country are the dry version of the condition, for which no effective treatment exists.

5 Apr 2018

New trial to test stem cell-based retinal implant for dry age-related macular degeneration

Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for use in people with advanced dry age-related macular degeneration.

4 Apr 2018

Immune cells can repopulate in the retina after elimination, mice study shows

Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute.

21 Mar 2018

Stem cell-derived ocular cells treat severe AMD

In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.

19 Mar 2018

New NIH study aims to identify biomarkers of AMD progression

A new clinical study led by the National Eye Institute, part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration.

26 Feb 2018

Fight for Sight awards new grants for 13 vital eye research projects

Fight for Sight, the leading eye research charity, has awarded grants totaling over £180,000 for thirteen vital research projects in partnership with nine different organizations.

2 Feb 2018

Pixium Vision announces successful implantation and activation of PRIMA Bionic Vision System

Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today the world’s first successful human implantation and activation of PRIMA, its new generation miniaturized wireless photovoltaic sub-retinal implant, in a patient with severe vision loss from atrophic dry Age-related Macular Degeneration (AMD).

27 Jan 2018